Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

SYT Inhibitors

SYT inhibitors, short for Synaptotagmin inhibitors, represent a class of chemical compounds designed to modulate the activity of Synaptotagmin proteins. Synaptotagmins are a family of membrane proteins that play a crucial role in regulating synaptic vesicle exocytosis, a fundamental process in neurotransmission. These proteins are primarily found in nerve cells and serve as calcium sensors, enabling precise timing and coordination of neurotransmitter release. SYT inhibitors function by interfering with the calcium-binding properties of Synaptotagmins, thereby influencing their ability to trigger the fusion of synaptic vesicles with the cell membrane. This modulation of Synaptotagmin activity can have significant downstream effects on synaptic transmission and impacts neuronal communication in various physiological contexts.

Structurally, SYT inhibitors can take on diverse forms, including small molecules, peptides, or engineered proteins. They are designed to interact with specific domains of Synaptotagmins involved in calcium binding, disrupting the normal calcium-dependent signaling cascade that leads to vesicle fusion. By inhibiting the calcium-sensing function of Synaptotagmins, these compounds fine-tune the release of neurotransmitters, which can be critical for controlling the strength and precision of synaptic transmission. While SYT inhibitors are primarily a subject of research in the realm of neuroscience and cellular biology, their development and application hold promise for shedding light on the intricacies of synaptic function and contributing to a deeper understanding of neurobiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine is a DNA methyltransferase inhibitor. By inhibiting DNA methylation, it can lead to the reactivation of silenced genes, potentially affecting SS18 expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine is another DNA methyltransferase inhibitor, and like 5-Azacytidine, it can alter gene expression patterns, potentially impacting SS18 levels.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate acts as a histone deacetylase inhibitor, influencing chromatin structure and gene expression, which may impact SS18 expression.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Romidepsin is a histone deacetylase inhibitor that has the potential to change chromatin structure and gene expression, possibly affecting SS18 levels.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic Acid is a short-chain fatty acid and histone deacetylase inhibitor, potentially leading to alterations in chromatin structure and SS18 expression.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram can inhibit proteasome activity and affect protein degradation pathways, potentially impacting the stability and expression levels of SS18.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a proteasome inhibitor that can alter protein degradation pathways, potentially affecting the stability and expression of SS18.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is another proteasome inhibitor, potentially altering the degradation and stability of SS18, thereby impacting its expression levels.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis, which could lead to a decrease in SS18 levels over time.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA polymerase, leading to decreased RNA synthesis and potentially impacting SS18 expression.